Decisions you can act on, from people who still do the work.

1. Healthcare investment and M&A

You get a clear yes, no, or yes-if — before you wire money.

• Target screening, including distressed assets and bankruptcy registers
• Buy-side due diligence: request lists by workstream (financial, commercial, legal and regulatory, operational, HR), management questions, verification of seller data against filings
• Seller-side data rooms and written answers to investor questionnaires
• Investment memos and committee papers: deal structure, liability settlement, turnaround budget, working-capital reserve, three-year outlook, conditions precedent
• Financial modelling: IRR, NPV, scenarios and sensitivities; operating benchmarks by facility type
• Critical review of third-party feasibility studies and valuations
• Joint ventures between regional groups and international operators: business plan, governance, foreign-investment licensing, NDAs, MoUs and LOIs
• Sectors examined: outpatient polyclinics, dental and dermatology centres, rehabilitation and behavioural health, medical-consumables and disinfectant manufacturing, wound care, technical services, hospital ancillary services

2. Government tenders and procurement

You bid at a price you can defend, and you know when the cash arrives.

• National procurement and e-tendering platforms in Saudi Arabia: tender analysis and supplier registration across government buyers
• Item-level costing: landed cost, currency, freight, VAT, risk, device listing and origin
• Opening-report analysis, awarded-price benchmarking, historical consumption analysis
• Purchase-order tracking through delivery and goods receipt; PO forecasting
• Cash-flow projection built around government collection cycles
• Expressions of interest for hospital privatisation and PPP programmes

3. Regulatory and quality

Your product or facility passes the first time, or you know exactly why not.

• Food-supplement registration with the SFDA: dossiers, reviewer comments, safety justifications, appeals
• Cosmetics notification, medical-device listing and authorised-representative arrangements
• GMP and quality-system advice from a production pharmacist
• Calibration, temperature mapping, autoclave, HVAC and cleanroom qualification: scoping and vendor management to the SFDA GMP guide, ISO 14644 and ISO/IEC 17025
• Manufacturer and supplier audits for food supplements and cosmetics; supplier readiness scoring

4. Supply chain and finance

You secure the supplier, the terms and the working capital.

• Manufacturer and supplier partnerships from Türkiye into the Gulf, the Middle East and Africa
• Agency, distribution and exclusivity agreements: drafting, redlining, negotiation
• Supply-chain finance feasibility: profit with and without bank financing against your buyer's payment cycle
• Third-party logistics, bonded-zone storage and fulfilment agreements; cold-chain monitoring

5. Market research and feasibility

You see the market as it is, sized from the bottom up.

• Category-first market studies with weighted scoring; shelf-price benchmarks
• PESTLE, five-forces, segmentation, competitor mapping, TAM/SAM/SOM sizing
• Financial feasibility for products, stores, clinics and platforms
• Healthcare real estate: medical-village concepts, outpatient benchmarks, shared clinical workspace and co-working models

6. E-commerce and performance marketing — see E-commerce.

7. Healthcare AI — vendor evaluation, regulatory pathway, pilots and market entry. See Healthcare AI.

8. Establishing and growing healthcare companies

You get a company that can trade — and one an investor will want to buy.

• Business plans, investor decks and funding structures for new healthcare service companies
• Sales funnels, KPI plans, job descriptions and first hires
• Shareholder reporting, funding reconciliation and preparation for acquisition by investors

9. Cross-border business development

You enter with a partner, a price and a first order.

• Turkish companies entering the Gulf and Africa: partner search, pricing, registration, first shipments
• Gulf investors entering Türkiye and Egypt: opportunity screening, local diligence, site and partner evaluation
• Trade-fair coverage in Istanbul with written supplier meeting reports
• Medical-travel and referral programme design for institutions and governments

Recent work includes an investment review for a urology and sexual-health centre in Hargeisa, Somaliland, and a health-sector consultation project in Mauritania in September 2022.